表　題	著者名	誌 名
Oncology
Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulatin PI3K/Akt and MAPK signaling pathways.	Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y:	Cancer Lett 328 (2): 353-361, 2013
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma.	Hinotsu S, Kawai K, Ozono S, Tsushima T, Tokuda N, Nomata K, Naito S,Akaza H:	Int J Clin Oncol 18 (1): 68-74, 2013
YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.	Takeuchi A, Shiota M, Tatsugami K, Yokomizo A, Kuroiwa K, Dejima T, Tanaka S, Itsumi M, Eto M, Naito S:	Cancer Immunol Immunother 62 (3): 517-527, 2013
STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma.	Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; the Japan Immunotherapy SNPs-Study Group for Kidney Cancer:	Eur Urol 63 (4): 745-752, 2013
Changes in perioperative management of radical prostatectomy using clinical pathways according to a standardized care plan: a multi-institutional study.	Okamura K, Nojiri Y, Tanaka Y, Nagae H, Arai Y, Matsuda T, Hattori R, Hashine K, Naito S, Hasegawa T:	Int J Urol 20 (3): 337-343, 2013
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.	Kashiwagi E, Shiota M, Yokomizo A, Itsumi M, Inokuchi J, Uchiumi T, Naito S:	Endocr Relat Cancer 20 (3): 431-441, 2013
Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer.	Itsumi M, Shiota M, Yokomizo A, Kashiwagi E, Takeuchi A, Tatsugami K, Inokuchi J, Song Y, Uchiumi T, Naito S:	J Mol Endocrinol 50 (3): 401-409, 2013
Efficacy and safety of Axitinib versus Sorafenib in metastatic renal cell carcinoma: Subgroup analysis of Japanese patients from the global randomized phase 3 AXIS trial.	Ueda T, Uemura H, Tomita Y, Tsukamoto T, Kanayama H, Shinohara N, Tarazi J, Chen C, Kim S, Ozono S, Naito S, Akaza H:	Jpn J Clin Oncol 43 (6): 616-628, 2013
Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.	Miyazaki J, Hinotsu S, Ishizuka N, Naito S, Ozono S, Akaza H, Nishiyama H:	Jpn J Clin Oncol 43 (8): 827-834, 2013
3-decenoic acid derivatives induce autophagic cell death through the down-regulation of E2F1.	Shinohara H, Noguchi S, Kumazaki M, Yamada N, Ito T, Oyama M, Ito Y, Otsuki Y, Naito S, Iinuma M, Akao Y:	J Toxicol Res 3 (1): 29-34, 2013
Influence of hospital surgical volume of radical prostatectomy on quality of perioperative care.	Nojiri Y, Okamura K, Tanaka Y, Yanaihara H, Sassa N, Hattori R, Machida J, Hashine K, Matsuda T, Arai Y, Naito S, Hasegawa T:	Int J Clin Oncol 18 (5): 898-904, 2013
cs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells.	Noguchi S, Yamada N, Kumazaki M, Yasui Y, Iwasaki J, Naito S, Akao Y:	Cell Death Dis 4: e482, 2013
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB-1, and androgen receptor.	Shiota M, Kashiwagi E, Yokomizo A, Takeuchi A, Dejima T, Song Y, Tatsugami K, Inokuchi J, Uchiumi T, Naito S:	Prostate 73 (12): 1336-1344, 2013
Glyoxalase 1 as a candidate for indicating the metastatic potential of SN12C human renal cell carcinoma cell clones.	Tanaka T, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Tokuda K, Hirakawa K, Yashiro M, Naito S, Nakamura K:	Oncol Rep 30 (5): 2365-2370, 2013
Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan.	Hirono M, Kobayashi M, Tsushima T, Obara W, Shinohara N, Ito K, Eto M, Takayama T, Fujii Y, Nishikido M, Kimura G, Kishida T, Takahashi M, Miyao N, Naya Y, Abe T, Fujioka T, Ito K, Naito S; Members of the Japanese Society of Renal Cancer:	BMC Cancer 13:447, 2013
Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients.	Naito S, Kinoshita H, Kondo T, Shinohara N, Kasahara T, Saito K, Takayama T, Masumori N, Takahashi W, Takahashi M, Terachi T, Ozono S, Naito S, Tomita Y:	Urology 82 (4): 846-851, 2013
Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.	Fushimi F, Taguchi K, Izumi H, Kohno K, Kuwano M, Ono M, Nakashima Y, Takesue T, Naito S, Oda Y:	Virchows Arch 463 (4): 553-562, 2013
Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.	Imada K, Shiota M, Kohashi K, Kuroiwa K, Song Y, Sugimoto M, Naito S, Oda Y:	Clin Cancer Res 19 (17): 4638-4650, 2013
Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score.	Akaza H, Hinotsu S, Usami M, Ogawa O, Kitamura T, Suzuki K, Tsukamoto T, Naito S, Namiki M, Hirao Y, Murai M:	Prostate Int 1 (2): 81-88, 2013
Infectious Disease
Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.	Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, Kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T:	J Infect Chemother 19 (3): 393-403, 2013
Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan.	Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Takahashi S, Hayami H, Yamamoto S, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Ito S, Narita H, Kanokogi M, Sumii T, Ito K, Hosobe T, Kawai S, Kawano H, Takayama K, Yamaguchi T, Endo K, Yamauchi T, Maeda S, Yoh M, Horie M, Ito M, Chokyu H, Ihara H, Akiyama K, Uno S, Monden K, Kaji S, Nishimura H, Kawahara M, Sato T, Konishi T, Nishi S, Ishihara S, Yoshioka M:	J Infect Chemother 19 (4): 571-578, 2013
A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice.	Dejima T, Shibata K, Yamada H, Takeuchi A, Hara H, Eto M, Naito S, Yoshikai Y:	Microbiol Immunol 57 (12): 833-841, 2013
Neurourology
Novel effect of 2-aminoethoxydiphenylborate through inhibition of calcium sensitization induced by Rho kinase activation in human detrusor smooth muscle.	Shahab N, Kajioka S, Takahashi R, Hayashi M, Nakayama S, Sakamoto K, Takeda M, Masuda N, Naito S:	Eur J Pharmacol 708 (1-3): 14-20, 2013
Involvement of IP3-receptor activation in endothelin-1-induced Ca2+ influx in rat pulmonary small artery.	Kato K, Okamura K, Hatta M, Morita H, Kajioka S, Naito S, Yamazaki J:	Eur J Pharmacol 720 (1-3): 255-263, 2013
Hyperexcitability of bladder afferent neurons associated with reduction of Kv 1.4 α-subunit in rats with spinal cord injury.	Takahashi, R, Yoshizawa T, Yunoki T, Tyagi P, Naito, S de Goat WC and Yoshimura N:	J Urol 190 (6): 2296-2304, 2013
Involvement of IP3-receptor activation in endothelin-1-induced Ca2+ influx in rat pulmonary small artery.	Kato K, Okamura K, Hatta M, Morita H, Kajioka S, Naito S, Yamazaki J:	Eur J Pharmacol 720 (1-3): 255-263, 2013